Study guide

11.1 Diabetic Ketoacidosis (DKA), Maternal Hypoglycemia & Endocrine Resuscitation in Pregnancy

C-OBE Obstetric Emergencies Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Maternal Assessment, Risk Stratification & Early Warning Systems

1.1 Pre-Existing Medical, Surgical & Obstetric Comorbidities in Emergency Risk Stratification 1.2 Dynamic Antepartum & Intrapartum Risk Assessment 1.3 Maternal Early Warning Systems (MEWS/MEWT) & Critical Triage Physical Assessment 1.4 Alliance for Innovation on Maternal Health (AIM) Safety Bundles & Emergency Readiness

2 Chapter 2: Obstetric Hemorrhage — Etiology, Assessment & Uterotonics

2.1 Postpartum Hemorrhage Etiology (4 T's) & Quantitative Blood Loss (QBL) 2.2 Uterotonic Pharmacology & Stepwise Administration Protocols 2.3 Tranexamic Acid (TXA) Protocols & Hemorrhage Timing

3 Chapter 3: Obstetric Hemorrhage — Mechanical Interventions, Placental Disorders & Transfusion

3.1 Intrauterine Tamponade Balloons, Compression Sutures & Surgical Hemostasis 3.2 Ectopic Pregnancy, Placenta Previa, Accreta Spectrum (PAS), Abruption & Vasa Previa 3.3 Obstetric DIC, Coagulopathy & Massive Transfusion Protocol (MTP)

4 Chapter 4: Hypertensive Disorders of Pregnancy & Preeclampsia with Severe Features

4.1 Classification & Spectrum of Hypertensive Disorders of Pregnancy 4.2 Preeclampsia with Severe Features: Pathophysiology & End-Organ Damage 4.3 Diagnostic Evaluation, Laboratory Triggers & Fetal Surveillance in Preeclampsia

5 Chapter 5: Hypertensive Crisis, Eclampsia & Magnesium Sulfate Therapy

5.1 Acute Severe Hypertension & First-Line Antihypertensive Protocols 5.2 Eclampsia Recognition, Seizure Management & Airway Protection 5.3 Magnesium Sulfate Neuroprotection/Seizure Prophylaxis Protocols, Monitoring & Toxicity Reversal 5.4 HELLP Syndrome & Hepatic Crisis Management

6 Chapter 6: Maternal Resuscitation, Cardiac Arrest & Perimortem Cesarean

6.1 Maternal ACLS Modifications & Cardiopulmonary Resuscitation Physiology 6.2 Etiologies of Maternal Arrest & Structured Emergency Response 6.3 Perimortem Cesarean Delivery (PMCD / Resuscitative Hysterotomy)

7 Chapter 7: Amniotic Fluid Embolism & Maternal Shock States

7.1 Amniotic Fluid Embolism (AFE): Pathophysiology & Clinical Presentation 7.2 A-OK Protocol, Hemodynamic Support & Critical Care in AFE 7.3 Maternal Shock States: Hemorrhagic, Distributive, Cardiogenic & Obstructive

8 Chapter 8: Acute Intrapartum Delivery Emergencies

8.1 Shoulder Dystocia: Recognition, Timing & Primary HELPERR Sequence 8.2 Advanced Shoulder Dystocia Maneuvers & Neonatal Brachial Plexus Injury Prevention 8.3 Umbilical Cord Prolapse Recognition & Emergent Decompression Protocols

9 Chapter 9: Uterine Inversion, Malpresentation & Obstetric Trauma

9.1 Acute Uterine Inversion: Recognition, Tocolysis & Manual/Surgical Reduction 9.2 Emergency Vaginal Breech Extraction & Head Entrapment Maneuvers 9.3 Maternal Trauma: Primary/Secondary Survey, Placental Abruption & Fetomaternal Hemorrhage

10 Chapter 10: Maternal Sepsis, Intraamniotic Infection & Severe Infections

10.1 Maternal Sepsis: Physiological Criteria, S.O.S. Score & omSOFA 10.2 The Maternal Sepsis Hour-1 Bundle & Fluid/Vasopressor Optimization 10.3 Intraamniotic Infection (Triple I / Chorioamnionitis) & Severe Endometritis 10.4 Severe Pyelonephritis, Maternal Pneumonia & Severe Peripartum Infections

11 Chapter 11: Endocrine, Cardiovascular, Respiratory & Neurologic Emergencies

11.1 Diabetic Ketoacidosis (DKA), Maternal Hypoglycemia & Endocrine Resuscitation in Pregnancy 11.2 Peripartum Cardiomyopathy (PPCM), Acute Heart Failure, Acute Coronary Syndromes & Maternal Arrhythmias 11.3 Status Asthmaticus, Pulmonary Edema & ARDS in Pregnancy 11.4 Status Epilepticus, Acute Stroke & Cerebral Venous Sinus Thrombosis (CVST)

12 Chapter 12: Thromboembolism, Hepatorenal Disorders & Toxicologic Emergencies

12.1 Venous Thromboembolism (DVT/PE) Diagnosis, Treatment & Peripartum Anticoagulation 12.2 Acute Fatty Liver of Pregnancy (AFLP / Swansea Criteria) & Acute Kidney Injury 12.3 Peripartum Substance Overdose, Opioid Toxicity & Naloxone Administration

13 Chapter 13: Obstetric Anesthesia Emergencies & Critical Complications

13.1 High Spinal / Total Spinal Anesthesia & Aspiration Pneumonitis 13.2 Local Anesthetic Systemic Toxicity (LAST) & 20% Lipid Emulsion Rescue Protocol 13.3 Post-Dural Puncture Headache (PDPH), Epidural Hematoma & Abscess 13.4 Malignant Hyperthermia in Obstetric Anesthesia & Dantrolene Protocol

14 Chapter 14: Professional Practice, Team Communication, Debriefing & Health Equity

14.1 Crisis Resource Management (CRM), TeamSTEPPS & Structured Communication 14.2 Multidisciplinary Emergency Debriefing, Morbidity & Mortality, and Systems Learning 14.3 Perinatal Racial/Ethnic Disparities, Implicit Bias Mitigation & Respectful Maternity Care 14.4 Legal, Ethical, Documentation & EMTALA Standards in Obstetric Emergencies

11.1 Diabetic Ketoacidosis (DKA), Maternal Hypoglycemia & Endocrine Resuscitation in Pregnancy

Key Takeaways Explain This Topic AI

Pregnancy is a state of accelerated ketosis driven by human placental lactogen (hPL), progesterone, and cortisol; diabetic ketoacidosis (DKA) can develop rapidly at markedly lower serum glucose thresholds, frequently presenting as euglycemic DKA with blood glucose <200 mg/dL.

DKA in pregnancy carries a high fetal mortality rate of 10% to 25% due to severe transplacental acidosis, maternal osmotic hypovolemia, hypoperfusion, and electrolyte shifts; non-reassuring fetal heart rate patterns (late decelerations, minimal variability) are common during acute maternal acidemia and reliably resolve with maternal resuscitation.

Emergency delivery is strictly contraindicated during acute maternal ketoacidosis; maternal resuscitation with IV isotonic crystalloid (500–1,000 mL/h for the first 2–4 h, adjusted with obstetric input), continuous regular insulin infusion (0.1 unit/kg/h), potassium repletion once K <5.0 mEq/L (insulin delayed while K <3.5), and adding 5–10% dextrose when glucose falls below 250 mg/dL must precede any delivery considerations.

Thyroid storm in pregnancy is a hypermetabolic life-threatening crisis diagnosed using the Burch-Wartofsky Point Scale (score ≥45); pharmacotherapy requires a strict sequence of propylthiouracil (PTU), followed at least 1 hour later by saturated solution of potassium iodide (SSKI) or Lugol's solution, alongside IV beta-blockade (propranolol/esmolol) and IV dexamethasone.

Insulin requirements fall by approximately half or more the moment the placenta is delivered as human placental lactogen, progesterone, and cortisol are withdrawn, so insulin must be reduced pre-emptively at delivery; severe maternal hypoglycemia (altered mental status or need for third-party assistance) is treated with 25 g of 50% dextrose intravenously or glucagon 1 mg intramuscularly when there is no access, and because it mimics eclampsia, stroke, and magnesium toxicity a point-of-care glucose is mandatory in every obstetric patient with a seizure or altered mental status.

Last updated: October 2026

Diabetic Ketoacidosis (DKA) in Pregnancy: Euglycemic DKA & Resuscitation

Diabetic Ketoacidosis (DKA) in pregnancy is an acute, life-threatening metabolic emergency characterized by the triad of hyperglycemia (or relative euglycemia), hyperketonemia, and high-anion-gap metabolic acidosis. While DKA complicates approximately 1% to 3% of pregnancies affected by pregestational Type 1 diabetes, it can also occur in Type 2 and gestational diabetes mellitus (GDM). Maternal mortality from DKA has decreased to <1% in modern critical care units, but fetal mortality remains alarmingly high at 10% to 25% per episode. Immediate recognition, physiologic stabilization, and avoidance of premature operative delivery during acute acidemia are essential.

1. Pathophysiology of Accelerated Ketosis in Pregnancy

Pregnancy is a state of profound physiologic insulin resistance coupled with enhanced lipolysis, creating what is classically described as "accelerated starvation" and "accelerated ketosis." +---------------------------------------------------------------------------------------------------+

  • | METABOLIC ALTERATIONS DRIVING ACCELERATED KETOSIS |
  • | |
  • | 1. PLACENTAL CONTRA-INSULIN HORMONES: |
  • | • Human Placental Lactogen (hPL), Placental Growth Hormone, Progesterone, Cortisol, and |
  • | Prolactin rise progressively across gestation, inducing peripheral insulin resistance. |
  • | • Hepatic gluconeogenesis and glycogenolysis increase while peripheral glucose uptake declines.|
  • | |
  • | 2. ACCELERATED LIPOLYSIS & KETOGENESIS: |
  • | • Fasting states trigger rapid hydrolysis of maternal triglycerides into Free Fatty Acids. |
  • | • Carnitine Palmitoyltransferase-1 (CPT-1) shuttles fatty acids into hepatic mitochondria. |
  • | • Beta-oxidation generates massive excess of Acetoacetate and Beta-Hydroxybutyrate (BOHB). |
  • | |
  • | 3. DIMINISHED BUFFERING CAPACITY: |
  • | • Progesterone-driven central hyperventilation produces chronic respiratory alkalosis. |
  • | • Compensatory renal bicarbonate excretion reduces baseline serum [HCO3-] to 18–22 mEq/L |
  • | (normal arterial PaCO2 is 28–32 mmHg). |
  • | • A minor acid load rapidly exhausts maternal buffering reserves, precipitating profound |
  • | metabolic acidosis much earlier than in non-pregnant patients. |
  • | |
  • | 4. INCREASED GLOMERULAR FILTRATION RATE (GFR): |
  • | • High GFR and lowered renal tubular threshold for glucose cause pronounced glucosuria. |
  • | • Lower serum glucose levels are maintained even in the presence of severe absolute or |
  • | relative insulin deficiency, promoting euglycemic DKA. |
  • +---------------------------------------------------------------------------------------------------+
  • 2. Euglycemic DKA: Diagnostic Criteria & Pitfalls

In non-pregnant adults, DKA is diagnosed with glucose ≥200 mg/dL or a known history of diabetes (2024 adult consensus), and about 10% present with euglycemic DKA. In pregnancy, up to 30% to 50% of DKA cases present as "Euglycemic DKA" , defined as ketoacidosis occurring with blood glucose levels <200 mg/dL .

Clinical Triggers for Euglycemic DKA

Hyperemesis Gravidarum / Prolonged Fasting: Inability to maintain caloric intake leads to starvation ketosis combined with omitted insulin doses.

Infection / Sepsis: Acute pyelonephritis, chorioamnionitis, pneumonia, or viral gastroenteritis.

Antenatal Corticosteroids: Betamethasone or dexamethasone administration for fetal lung maturity triggers an acute surge in hepatic glucose output and peripheral insulin resistance.

Beta-Sympathomimetic Tocolytics: Terbutaline enhances hepatic glycogenolysis and lipolysis.

Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors: SGLT2 inhibitors cause heavy renal glucosuria, low insulin secretion, and uninhibited lipolysis (strictly contraindicated in pregnancy, but cases occur in inadvertent early pregnancy exposure).

Insulin Pump Malfunction / Non-Adherence: Subcutaneous infusion site failure or catheter disconnection.

Diagnostic Laboratory Criteria

  • Laboratory Parameter Normal Pregnancy Value Mild DKA in Pregnancy Moderate-to-Severe DKA
  • Arterial / Venous pH 7.40 – 7.45 7.25 – 7.30 < 7.25 (Severe: < 7.00)
  • Serum Bicarbonate (HCO3-) 18 – 22 mEq/L 15 – 18 mEq/L < 15 mEq/L (Severe: < 10)
  • Serum Beta-Hydroxybutyrate < 0.5 mmol/L 3.0 – 5.0 mmol/L > 5.0 mmol/L
  • Serum Glucose 70 – 95 mg/dL (fasting) < 200 mg/dL (Euglycemic) ≥ 200 mg/dL
  • Anion Gap [Na - (Cl + HCO3)] 6 – 10 mEq/L 12 – 16 mEq/L > 16 mEq/L
  • Effective Osmolality 275 – 285 mOsm/kg 285 – 300 mOsm/kg > 300 mOsm/kg

Clinical Diagnostic Pearl: Urine dipstick tests detect acetoacetate via the nitroprusside reaction, but do NOT detect beta-hydroxybutyrate , which is the predominant circulating ketoacid in severe DKA (often at an 8:1 ratio over acetoacetate). Always measure quantitative serum beta-hydroxybutyrate and calculate the serum anion gap when evaluating a pregnant diabetic with nausea, vomiting, or tachypnea, regardless of normal capillary blood glucose.

3. Step-by-Step Resuscitation Protocol for Maternal DKA

The management of DKA in pregnancy requires aggressive crystalloid rehydration, continuous IV regular insulin infusion, careful potassium management, and prompt addition of 5–10% dextrose once glucose falls below 250 mg/dL to clear ketonemia, with obstetric input throughout (2024 adult consensus thresholds). +---------------------------------------------------------------------------------------------------+

  • | STEP-BY-STEP DKA RESUSCITATION PROTOCOL |
  • | |
  • | STEP 1: AGGRESSIVE INTRAVENOUS CRYSTALLOID VOLUME EXPANSION |
  • | • Typical total fluid deficit is 4 to 6 Liters. |
  • | • Hours 1-4: isotonic crystalloid at **500 to 1,000 mL/hour** (2024 adult consensus); |
  • | • Then adjust fluid type and rate to hydration status and corrected sodium. |
  • | - Corrected Serum Sodium = Measured Na + 0.016 * (Glucose - 100). |
  • | - If corrected Na is normal or elevated (>135 mEq/L) -> Switch to 0.45% NaCl. |
  • | - If corrected Na is low (<135 mEq/L) -> Continue 0.9% NaCl. |
  • | |
  • | STEP 2: CONTINUOUS INTRAVENOUS REGULAR INSULIN INFUSION |
  • | • Check serum potassium BEFORE initiating insulin! (See Step 3). |
  • | • Administer **Continuous IV Regular Insulin at 0.1 units/kg/hour** (or 0.14 U/kg/h without |
  • | bolus, or IV bolus 0.1 U/kg followed by 0.1 U/kg/h). |
  • | • Target rate of glucose reduction: **50 to 75 mg/dL per hour**. |
  • | • If glucose does not drop by 50 mg/dL in the first 2 hours, double the insulin infusion rate. |
  • | • NEVER administer intermittent subcutaneous insulin during acute DKA due to erratic absorption.|
  • | |
  • | STEP 3: POTASSIUM REPLETION ALGORITHM (CRITICAL STEP) |
  • | • Insulin drives potassium into cells, causing rapid, life-threatening hypokalemia. |
  • | • If Serum K < 3.5 mEq/L: **HOLD INSULIN**; infuse KCl about 10 mEq/h until K > 3.5 mEq/L. |
  • | • If Serum K 3.5 to 5.0 mEq/L: Start insulin AND add **20 to 30 mEq KCl per liter of IV fluid** |
  • | to maintain serum potassium strictly between 4.0 and 5.0 mEq/L. |
  • | • If Serum K > 5.0 mEq/L: No potassium until K < 5.0; recheck 2 h after insulin, then every 4 h. |
  • | |
  • | STEP 4: ADDING DEXTROSE (THE EUGLYCEMIC DEXTROSE TRAP) |
  • | • When serum glucose falls **below 250 mg/dL**: |
  • | - **ADD 5-10% DEXTROSE** to the IV infusion (for example, D5 in 0.45% NaCl at 150–250 mL/h). |
  • | - **DO NOT STOP THE INSULIN INFUSION!** Reduce insulin rate to 0.05–0.1 units/kg/hour. |
  • | - Rationale: Insulin is required to shut down hepatic lipolysis and ketone production. |
  • | Dextrose provides the substrate necessary to continue insulin therapy safely without causing |
  • | maternal hypoglycemia until ketoacidosis resolves (criteria in STEP 5). |
  • | |
  • | STEP 5: RESOLUTION CRITERIA & TRANSITION TO SUBCUTANEOUS REGIMEN |
  • | • DKA resolution (2024 adult consensus): plasma ketone (beta-hydroxybutyrate) < 0.6 mmol/L |
  • | AND venous pH >= 7.3 or Serum HCO3 >= 18 mEq/L; ideally glucose < 200 mg/dL. |
  • | Do not use the anion gap or urine ketones as resolution criteria. |
  • | Pregnancy: no separate criteria; the consensus calls for expert senior medical and |
  • | obstetric input. Transition once the patient is alert and tolerating oral nutrition. |
  • | • Transition: Administer subcutaneous basal insulin (e.g., Glargine/Detemir/NPH) **2 hours |
  • | BEFORE discontinuing the intravenous insulin infusion** to prevent rebound ketoacidosis. |
  • +---------------------------------------------------------------------------------------------------+
  • Bicarbonate & Phosphate Therapy in Maternal DKA

Sodium Bicarbonate: Routine use is contraindicated because it worsens intracellular and fetal acidosis (paradoxical cerebral/placental acidosis via rapid CO2 diffusion across the blood-brain and placental barriers) and causes hypokalemia. Consider ONLY for severe maternal acidemia with pH < 7.0 (2024 adult consensus) (100 mmol sodium bicarbonate in 400 mL sterile water with 20 mEq KCl over 2 hours until pH >= 7.00).

Phosphate Repletion: Serum phosphate shifts intracellularly with insulin. Replete with potassium phosphate only if serum phosphate drops < 1.0 mg/dL to prevent respiratory muscle weakness or rhabdomyolysis.

  • 4. Fetal Physiology, Electronic Fetal Monitoring (EFM) & Delivery Rules
  • Impact of Maternal Ketoacidosis on the Fetus

Transplacental Acid Transfer: Ketoacids and hydrogen ions cross the placenta, causing fetal metabolic acidosis and severe myocardial depression.

Uteroplacental Hypoperfusion: Maternal osmotic diuresis and severe intravascular hypovolemia reduce uterine artery blood flow by up to 40% to 50%.

Leftward Shift of Maternal Oxyhemoglobin Curve (Alkalinization/2,3-DPG depletion): Severe acidemia followed by rapid shifts impairs oxygen unloading at the intervillous space.

Fetal Hyperinsulinemia & Hypoxia: High maternal glucose crossing the placenta stimulates fetal pancreatic beta-cells to secrete insulin, increasing fetal metabolic rate and oxygen consumption in the face of compromised placental delivery. +---------------------------------------------------------------------------------------------------+

  • | CARDINAL RULE OF OBSTETRIC DKA MANAGEMENT |
  • | |
  • | • NON-REASSURING EFM PATTERNS ARE EXPECTED: |
  • | - Continuous EFM during active DKA frequently demonstrates fetal tachycardia, minimal or |
  • | absent baseline variability, and repetitive late decelerations. |
  • | |
  • | • ABSOLUTE CONTRAINDICATION TO IMMEDIATE OPERATIVE DELIVERY: |
  • | - **DO NOT PERFORM AN EMERGENCY CESAREAN DELIVERY FOR FHR ABNORMALITIES DURING ACTIVE DKA!** |
  • | - Maternal acidosis, dehydration, and electrolyte derangements make maternal surgical and |
  • | anesthetic mortality extraordinarily high. |
  • | - The compromised fetus cannot tolerate delivery stress and suffers high neonatal mortality. |
  • | - Resuscitation of the mother *in utero* simultaneously resuscitates the fetus: as maternal |
  • | volume is restored and arterial pH normalizes, fetal heart rate variability and decelerations|
  • | typically resolve within 4 to 12 hours. |
  • | |
  • | • INDICATIONS FOR DELIVERY: |
  • | - Delivery is deferred until the mother is fully resuscitated and metabolic acidosis resolved. |
  • | - Emergency delivery is reserved only for catastrophic non-reassuring fetal status that |
  • | persists AFTER complete maternal hemodynamic and biochemical stabilization, or for |
  • | independent obstetric catastrophes (e.g., severe placental abruption). |
  • +---------------------------------------------------------------------------------------------------+
  • 5. Thyroid Storm in Pregnancy: Evaluation & Stepwise Pharmacotherapy

Thyroid storm is an extreme, life-threatening manifestation of thyrotoxicosis characterized by multiorgan decompensation. It carries a maternal mortality rate of 10% to 20% and is triggered by infection, labor, cesarean delivery, preeclampsia, or non-adherence to antithyroid medications.

Burch-Wartofsky Point Scale (BWPS)

The diagnosis of thyroid storm is clinical. The BWPS assigns points for:

Thermoregulatory Dysfunction: Temperature 99.0–99.9°F (5 pts) up to ≥104.0°F (30 pts).

Central Nervous System Effects: Mild agitation (10 pts), delirium/psychosis/lethargy (20 pts), coma/seizures (30 pts).

Gastrointestinal / Hepatic Dysfunction: Diarrhea, nausea, vomiting, abdominal pain (10 pts); unexplained jaundice (20 pts).

Cardiovascular Dysfunction: Tachycardia 100–109 bpm (5 pts) up to ≥140 bpm (25 pts); atrial fibrillation (10 pts); congestive heart failure (mild 5 pts to severe cardiogenic shock 15 pts).

Precipitating Event: Absent (0 pts), Present (10 pts).

Scoring: < 25 = Unlikely; 25–44 = Impending Storm; ≥ 45 = Highly Suggestive of Thyroid Storm .

Stepwise Multimodality Pharmacotherapy Protocol +---------------------------------------------------------------------------------------------------+

  • | STEPWISE THYROID STORM TREATMENT REGIMEN |
  • | |
  • | PILLAR 1: BLOCK NEW THYROID HORMONE SYNTHESIS (THIONAMIDES) |
  • | • **Propylthiouracil (PTU): 600 to 800 mg PO loading dose**, then **200 mg PO/NG every 4 hours**.|
  • | • PTU is preferred over methimazole in thyroid storm because PTU inhibits both new hormone |
  • | synthesis AND the peripheral conversion of T4 to active T3. |
  • | |
  • | PILLAR 2: INHIBIT PRE-FORMED THYROID HORMONE RELEASE (INORGANIC IODINE) |
  • | • **Saturated Solution of Potassium Iodide (SSKI) 5 drops PO every 6 hours** OR |
  • | **Lugol's Solution 8 drops PO every 6 hours** OR **Sodium Iodide 500 mg to 1 g IV every 12 h**. |
  • | • CRITICAL TIMING RULE: **GIVE IODINE AT LEAST 1 HOUR AFTER THE THIONAMIDE!** |
  • | - Rationale: Administering iodine before blocking organification fuels new hormone synthesis |
  • | (Jod-Basedow phenomenon), worsening the storm. Giving it ≥1 hour after PTU induces the |
  • | Wolff-Chaikoff effect, blocking the release of pre-formed T4 and T3 from the thyroid gland. |
  • | |
  • | PILLAR 3: ADRENERGIC BLOCKADE (BETA-BLOCKERS) |
  • | • **Propranolol: 60 to 80 mg PO every 4 to 6 hours**, or **1 to 2 mg slow IV push every 15 min**.|
  • | • Alternative: **Esmolol IV infusion** (500 mcg/kg load over 1 min, then 50–200 mcg/kg/min) in |
  • | ICU setting for rapid titration. |
  • | • Controls severe tachycardia, diaphoresis, and tremors; high-dose propranolol also inhibits |
  • | peripheral T4-to-T3 monodeiodination. |
  • | |
  • | PILLAR 4: BLOCK PERIPHERAL T4-TO-T3 CONVERSION & ADRENAL SUPPORT (STEROIDS) |
  • | • **Dexamethasone 2 mg IV every 6 hours** OR **Hydrocortisone 100 mg IV every 8 hours**. |
  • | • Inhibits peripheral T4-to-T3 conversion and treats potential relative adrenal insufficiency. |
  • | |
  • | PILLAR 5: SUPPORTIVE CARE & TRIGGER MANAGEMENT |
  • | • Active cooling blankets and **Acetaminophen** for hyperpyrexia. |
  • | • **AVOID ASPIRIN / SALICYLATES:** Aspirin displaces T4 and T3 from Thyroid-Binding Globulin |
  • | (TBG), dramatically increasing free active hormone levels and exacerbating the crisis. |
  • | • IV crystalloid rehydration and aggressive treatment of underlying infection or obstetric trigger.|
  • +---------------------------------------------------------------------------------------------------+
  • 6. Maternal Hypoglycemia & Insulin-Related Emergencies

Hypoglycemia is listed alongside ketoacidosis and insulin in the NCC endocrine outline because insulin therapy causes as many peripartum emergencies as it prevents. Pregnancy both increases the frequency of severe hypoglycemia and degrades the warning symptoms that normally protect against it.

Definitions and Why Pregnancy Blunts the Warning

  • Level Threshold Clinical Meaning
  • Level 1 (alert) Glucose < 70 mg/dL Requires treatment with fast-acting carbohydrate
  • Level 2 (clinically significant) Glucose < 54 mg/dL Neuroglycopenia begins; serious, immediately actionable

Level 3 (severe) Any value with altered mental status or requiring third-party assistance A medical emergency defined by function, not by a number

Counter-regulatory hormone responses are attenuated in pregnancy, and tight glycemic targets drive the adrenergic warning threshold downward, so hypoglycemia unawareness is common — particularly in type 1 diabetes during the first trimester , where nausea and vomiting compound erratic intake.

The Two High-Risk Windows

First trimester: nausea, vomiting, and aggressive glycemic targets combine to produce the highest rate of severe hypoglycemia in the entire pregnancy.

Immediately after delivery of the placenta — the "insulin cliff." Abrupt withdrawal of human placental lactogen, progesterone, and cortisol removes pregnancy-induced insulin resistance within minutes. Insulin requirements fall by roughly half or more the moment the placenta is delivered , and insulin sensitivity returns to pre-pregnancy levels over the following 1 to 2 weeks. A patient left on her late-pregnancy insulin dose after delivery will become profoundly hypoglycemic. Insulin must be reduced pre-emptively at delivery, not after a low reading ; breastfeeding lowers maternal glucose further.

Emergency Treatment +---------------------------------------------------------------------------------------------------+

  • | TREATMENT OF MATERNAL HYPOGLYCEMIA |
  • | |
  • | • CONSCIOUS, ABLE TO SWALLOW AND PROTECT THE AIRWAY ("Rule of 15"): |
  • | - Give 15 to 20 g of fast-acting oral carbohydrate (glucose tablets, juice, regular soda). |
  • | - Recheck capillary glucose in 15 minutes and repeat until the value exceeds 70 mg/dL. |
  • | - Follow with a longer-acting carbohydrate and protein snack to prevent rebound. |
  • | |
  • | • ALTERED MENTAL STATUS, SEIZING, OR UNABLE TO PROTECT THE AIRWAY: |
  • | - IV access available: 25 g of 50% dextrose (D50W, 50 mL) IV push, OR 100 to 250 mL of |
  • | 10% dextrose (D10W) through a peripheral line, then recheck in 15 minutes. |
  • | - NO IV access: glucagon 1 mg IM or subcutaneously (nasal glucagon 3 mg is an alternative). |
  • | Glucagon is ineffective in glycogen-depleted states such as starvation or advanced liver |
  • | failure, so obtain IV access and give dextrose as soon as possible. |
  • | |
  • | • AFTER THE ACUTE CORRECTION — DO NOT STOP AT ONE BOLUS: |
  • | - Start a continuous dextrose infusion when the cause is long-acting insulin or a |
  • | sulfonylurea, because a single bolus is outlawed by the duration of the offending drug. |
  • | - Stop or halve the offending insulin, identify the precipitant, and monitor for hours. |
  • +---------------------------------------------------------------------------------------------------+
  • The Differential Trap

Severe hypoglycemia produces seizure, obtundation, focal neurologic deficits, and agitation — meaning it perfectly mimics eclampsia, stroke, magnesium toxicity, local anesthetic systemic toxicity, sepsis, and amniotic fluid embolism . A point-of-care glucose is mandatory in every obstetric patient with a seizure or altered mental status , before the event is attributed to eclampsia. The reverse also holds: profound hypoglycemia is itself a hallmark of acute fatty liver of pregnancy (Section 12.2), where it reflects hepatic failure rather than excess insulin and demands treatment of the liver, not just the glucose. Transient maternal hypoglycemia is generally tolerated by the fetus; the fetal danger comes from maternal collapse, trauma, and hypoperfusion during a severe episode.

Loading diagram... Maternal Diabetic Ketoacidosis & Thyroid Storm Resuscitation Pathways